ID: ALA4163231

Max Phase: Preclinical

Molecular Formula: C21H20O4

Molecular Weight: 336.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1(C)CC(c2ccc(C)cc2)c2c(c3ccccc3oc2=O)O1

Standard InChI:  InChI=1S/C21H20O4/c1-13-8-10-14(11-9-13)16-12-21(2,23-3)25-19-15-6-4-5-7-17(15)24-20(22)18(16)19/h4-11,16H,12H2,1-3H3

Standard InChI Key:  RPOKSBKRVVZBBP-UHFFFAOYSA-N

Associated Targets(non-human)

Cyclooxygenase-2 1939 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 336.39Molecular Weight (Monoisotopic): 336.1362AlogP: 4.38#Rotatable Bonds: 2
Polar Surface Area: 48.67Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.74CX LogD: 3.74
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: 0.66

References

1. Rayar AM, Lagarde N, Martin F, Blanchard F, Liagre B, Ferroud C, Zagury JF, Montes M, Sylla-Iyarreta Veitía M..  (2018)  New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.,  146  [PMID:29407982] [10.1016/j.ejmech.2018.01.054]
2. Rayar AM, Lagarde N, Martin F, Blanchard F, Liagre B, Ferroud C, Zagury JF, Montes M, Sylla-Iyarreta Veitía M..  (2018)  New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.,  146  [PMID:29407982] [10.1016/j.ejmech.2018.01.054]

Source